ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 74 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $81,000 | +1520.0% | 16,483 | +1478.8% | 0.00% | – |
| Q4 2020 | $5,000 | -91.2% | 1,044 | -95.3% | 0.00% | – |
| Q2 2020 | $57,000 | -31.3% | 22,151 | -23.0% | 0.00% | -100.0% |
| Q1 2020 | $83,000 | -11.7% | 28,782 | +16.0% | 0.00% | 0.0% |
| Q4 2019 | $94,000 | -3.1% | 24,819 | +30.6% | 0.00% | 0.0% |
| Q3 2019 | $97,000 | +94.0% | 19,009 | +170.6% | 0.00% | 0.0% |
| Q1 2019 | $50,000 | -81.0% | 7,026 | -77.2% | 0.00% | -50.0% |
| Q4 2018 | $263,000 | -35.2% | 30,765 | +51.8% | 0.00% | -33.3% |
| Q3 2018 | $406,000 | +21.9% | 20,265 | +57.0% | 0.00% | 0.0% |
| Q2 2018 | $333,000 | -34.8% | 12,911 | -39.7% | 0.00% | -40.0% |
| Q1 2018 | $511,000 | -35.6% | 21,396 | -43.0% | 0.01% | -28.6% |
| Q3 2017 | $794,000 | +1103.0% | 37,518 | +1510.2% | 0.01% | +600.0% |
| Q4 2015 | $66,000 | – | 2,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
| Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
| Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
| Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
| DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
| Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
| EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
| DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |